Renaissance Technologies LLC raised its position in Simulations Plus, Inc. (NASDAQ:SLP – Free Report) by 807.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 181,500 shares of the technology company’s stock after purchasing an additional 161,500 shares during the quarter. Renaissance Technologies LLC’s holdings in Simulations Plus were worth $2,145,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in SLP. Tudor Investment Corp ET AL purchased a new position in shares of Simulations Plus during the third quarter valued at approximately $1,810,000. Nicholas Company Inc. raised its holdings in shares of Simulations Plus by 42.9% in the fourth quarter. Nicholas Company Inc. now owns 262,712 shares of the technology company’s stock worth $4,789,000 after buying an additional 78,854 shares during the period. GSA Capital Partners LLP lifted its stake in shares of Simulations Plus by 167.9% during the 4th quarter. GSA Capital Partners LLP now owns 62,322 shares of the technology company’s stock worth $1,136,000 after acquiring an additional 39,059 shares during the last quarter. Meros Investment Management LP bought a new stake in shares of Simulations Plus during the 4th quarter worth approximately $6,184,000. Finally, Nano Cap New Millennium Growth Fund L P purchased a new position in Simulations Plus during the 4th quarter valued at $1,768,000. 78.08% of the stock is owned by hedge funds and other institutional investors.
Insider Activity at Simulations Plus
In other news, Director Walter S. Woltosz sold 4,177 shares of the stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $18.44, for a total value of $77,023.88. Following the sale, the director owned 3,202,131 shares in the company, valued at $59,047,295.64. This represents a 0.13% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 19.10% of the stock is owned by company insiders.
Simulations Plus Stock Up 0.2%
Simulations Plus (NASDAQ:SLP – Get Free Report) last issued its earnings results on Thursday, July 9th. The technology company reported $0.30 EPS for the quarter, beating analysts’ consensus estimates of $0.23 by $0.07. Simulations Plus had a return on equity of 13.50% and a net margin of 9.88%.The firm had revenue of $21.89 million for the quarter, compared to analyst estimates of $20.90 million. As a group, equities analysts anticipate that Simulations Plus, Inc. will post 0.8 EPS for the current fiscal year.
Analyst Ratings Changes
Several equities analysts have commented on the company. William Blair downgraded Simulations Plus from an “outperform” rating to a “market perform” rating in a research report on Wednesday, June 17th. Craig Hallum downgraded Simulations Plus from a “buy” rating to a “hold” rating and set a $18.50 target price for the company. in a research report on Thursday, June 18th. Weiss Ratings raised shares of Simulations Plus from a “sell (d)” rating to a “sell (d+)” rating in a research note on Friday, July 10th. Finally, Wall Street Zen cut shares of Simulations Plus from a “buy” rating to a “hold” rating in a report on Saturday, June 13th. Seven research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Simulations Plus currently has a consensus rating of “Reduce” and an average target price of $17.25.
Get Our Latest Stock Report on SLP
About Simulations Plus
Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.
Featured Articles
- Five stocks we like better than Simulations Plus
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
- First Solar’s Profit Engine Faces a New Policy Test in Washington
Want to see what other hedge funds are holding SLP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Simulations Plus, Inc. (NASDAQ:SLP – Free Report).
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.
